Form 4 · Filed May 21, 2026, 09:49 PM UTC
NBIX/NEUROCRINE BIOSCIENCES INC
GORMAN KEVIN CHARLES — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 19, 2026 | M | other | 205,088 | $43 | $8,868,005 | 756,381 |
| May 19, 2026 | S | sell | 245,088 | $154 | $37,824,872 | 511,293 |
| May 19, 2026 | M | other | 205,088 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001201096-26-000010